Latest News

International Petroleum (TSX:IPCO) FY 2025 Results: Slower Finish To A Profitable Year International Petroleum (TSX:IPCO) closed FY 2025 with Q4 revenue of US$175.0 million and a basic EPS loss of US$0.05, capping off a year in which trailing twelve month revenue was US$681.5 million and EPS came in at US$0.25. Over recent periods, the company has seen quarterly revenue move between US$157.8 million and US$198.1 million and quarterly EPS swing from a profit of US$0.19 to a loss of US$0.05,...

Earnings setback and dividend affirmation come into focus Swatch Group (SWX:UHR) is in the spotlight after full year 2025 results showed sales of CHF 6,280 million and net income of CHF 3 million, alongside confirmation of an annual dividend of CHF 4.50 per share. See our latest analysis for Swatch Group. The annual results and dividend affirmation arrived alongside strong near term momentum, with a 1 day share price return of 2.43% and a 30 day share price return of 12.53%. However, the 3...

Why Celanese’s Latest Price Moves Matter for Investors Celanese (CE) is raising prices for acetic acid, vinyl acetate monomer, and related derivatives across the Western Hemisphere, a change that takes effect immediately or as existing contracts allow. For you as an investor, this type of pricing shift can influence revenue mix, margins, and customer relationships, especially in segments where Celanese supplies key inputs into industrial and consumer applications. See our latest analysis for...

Analyst coverage sparks fresh attention on NextDecade Capital One Financial has initiated coverage on NextDecade (NEXT) with a buy rating, putting fresh attention on the liquefied natural gas developer and its Rio Grande LNG and carbon capture projects in Texas. See our latest analysis for NextDecade. NextDecade's share price has climbed 6.3% over the past week and 10.0% over the past month to US$5.38, although the 1 year total shareholder return shows a 32.1% decline and the 5 year total...

In the past week, Edwards Lifesciences reported Q4 2025 sales of US$1,569.6 million and full-year 2025 sales of US$6.07 billion, alongside issuing 2026 guidance calling for first-quarter sales of US$1.55 billion to US$1.63 billion and full-year EPS of US$2.90 to US$3.05. While revenue continued to grow, the sharp drop in quarterly and full-year net income and EPS highlights how margin pressure and one-off factors are shaping Edwards’ profit profile as it invests behind its Structural Heart...

Novo Nordisk (CPSE:NOVO B) has filed a US patent lawsuit against Hims & Hers over a compounded oral semaglutide weight loss pill that used the active ingredient in Wegovy and Ozempic. The telehealth company withdrew the product within days after regulatory pressure from the FDA and the Department of Health and Human Services. Novo Nordisk is seeking a permanent injunction to limit copycat versions and protect its intellectual property in the obesity drug market. Novo Nordisk, best known for...

In January 2026, Sumitomo Mitsui Trust Group, Inc. reported results for the nine months ended December 31, 2025, with net income rising to ¥266,673 million and basic earnings per share from continuing operations increasing to ¥378.37. An interesting aspect of this update is that net interest loss narrowed to ¥38,032 million, highlighting improved earnings despite ongoing pressure on interest income. With earnings and per-share profitability higher over the nine-month period, we will now...

Teijin earnings trigger fresh look at the stock Teijin (TSE:3401) just posted nine month results to December 31, 2025, reporting sales of ¥659,878 million and a shift from prior year profit to a net loss of ¥58,970 million. The report included basic and diluted loss per share of ¥305.81 from continuing operations, compared with basic and diluted earnings per share of ¥264.66 in the same period a year earlier. See our latest analysis for Teijin. Despite the swing to a net loss, Teijin’s recent...

Pinterest (NYSE:PINS) has appointed Kecia Steelman, CEO of Ulta Beauty, to its Board of Directors. The company is rolling out a global restructuring plan that includes workforce and office space reductions. Management is prioritizing investment in AI technology to support shopping and visual discovery on the platform. Pinterest runs a visual discovery and social media platform built around images, search and idea curation, with a growing focus on shopping experiences. Across the sector,...

In early February 2026, Iovance Biotherapeutics reported real-world data for its commercial Amtagvi (lifileucel) therapy in advanced melanoma, showing what it called a best-in-class profile with unprecedented response rates, while reiterating extensive regulatory, manufacturing, and commercialization risks in its latest disclosures. The company’s detailed risk discussion highlights how fragile this apparent clinical success could be, with uncertainties around ex-U.S. approvals, manufacturing...

Why Unilever shares are on investor watch now Unilever (LSE:ULVR) has caught investor attention after a period of solid recent share performance, with the stock showing gains over the past week, month and past 3 months. See our latest analysis for Unilever. At a share price of £52.44, Unilever’s recent momentum is strongest over the past month, with a 10.54% 1 month share price return. Its 1 year total shareholder return of 7.43% and 5 year total shareholder return of 46.26% point to a...

Recent coverage around potential US cannabis regulatory shifts, including possible rescheduling to Schedule III and the SAFER Act, has brought Innovative Industrial Properties (IIPR) back into focus for income oriented real estate investors. See our latest analysis for Innovative Industrial Properties. IIPR’s latest share price of $47.99 sits against a backdrop of a 30 day share price return of 5.16% and a year to date share price return of 2.99%. The 1 year total shareholder return of 25.89%...

Bank of Montreal (TSX:BMO) is back in focus after analysts adjusted earnings estimates to reflect stronger trading expectations and a $200 million restructuring charge, along with leadership changes aimed at growing its global corporate banking business. See our latest analysis for Bank of Montreal. Those trading expectations and leadership changes are landing in a buoyant share price backdrop, with Bank of Montreal’s CA$197.49 share price sitting on a 30 day share price return of 7.01% and a...

With no fresh headline driving Hershey (HSY) today, the stock’s recent performance still stands out, with gains over the month, past 3 months, year to date, and the past year drawing investor attention. See our latest analysis for Hershey. Hershey’s recent 30 day share price return of 21.12% and 90 day share price return of 28.46%, against a 1 year total shareholder return of 49.44%, point to momentum building again after a softer multi year profile. If this move has you thinking about where...

In early February 2026, JPMorgan reiterated its positive stance on DLocal, citing record Total Payment Volume and gross profit alongside expanding cross-border payments infrastructure and new offerings like its Buy Now, Pay Later Fuse across multiple emerging markets. The analyst commentary underscored that DLocal’s growing network of local payment methods and product breadth is becoming a key differentiator for merchants seeking access to diverse, cash-light economies. Next, we’ll examine...

If you are wondering whether Novartis shares still offer value at around CHF 121.00, it helps to step back and look at what the current price actually implies about the company. The stock has shown solid momentum recently, with returns of 3.5% over 7 days, 6.1% over 30 days, 11.5% year to date, 27.8% over 1 year, 77.8% over 3 years and 89.7% over 5 years. Recent news flow around Novartis has focused on its position as a large pharma name and ongoing interest in its pipeline and portfolio...

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...

Qiagen (NYSE:QGEN) has launched new automation platforms for DNA and RNA extraction in clinical laboratories. The line up includes sustainability focused consumables, QIAsprint Connect, QIAsymphony Connect, and QIAmini. The products target a wide range of clinical and research settings that rely on scalable sample preparation workflows. Qiagen, trading at $51.08, is putting fresh attention on lab automation and sustainability with this new product wave. The company’s shares have returned...

Melexis (ENXTBR:MELE) is back in focus after releasing its Q4 and full year 2025 results, with quarterly figures pointing one way and the full year picture pointing another for revenue and earnings. See our latest analysis for Melexis. The earnings release appears to have sparked a short term reaction, with a 1 day share price return of 3.05% taking Melexis to €57.4. However, the 30 day share price return of an 8.67% decline and 1 year total shareholder return of 7.18% suggest only modest...

Recent share performance and business profile Science Applications International (SAIC) has been in focus for investors after a month return of about a 14% decline, contrasting with an 8.3% gain over the past 3 months and a 5 year total return of 11.8%. The Reston based contractor generates about US$7.35b in annual revenue and US$371m in net income, providing technical, engineering and enterprise IT services across U.S. defense, intelligence and civilian agencies. See our latest analysis for...

Bausch Health Companies has recently attracted renewed investor attention as it works to cut its sizeable debt, address legacy legal issues, and reshape its portfolio across eye health and specialty pharmaceuticals. An interesting angle is how growing social media visibility of Bausch’s key brands is drawing in more retail investors and amplifying interest in its ongoing turnaround efforts. We’ll now examine how this increased focus on Bausch’s debt reduction progress and turnaround...

Applied Digital recently reported a year-over-year revenue increase of 250% and locked in multiple 15-year AI data center leases, including an US$11.00 billion agreement with CoreWeave at its Polaris Forge 1 campus and a long-term contract with a U.S.-based hyperscaler for 200 megawatts at Polaris Forge 2. These contracts, together with more than US$16.00 billion in total long-term lease commitments and new project financing, mark a decisive shift toward recurring AI infrastructure revenue...

Wheaton Precious Metals (TSX:WPM) has outlined a leadership succession plan with President Haytham Hodaly set to become CEO. Co founder and current CEO Randy Smallwood will transition to non executive Chair of the Board. The change is scheduled to take effect on March 31, 2026, signaling a planned handover rather than an abrupt shift. For investors watching TSX:WPM, this is a meaningful corporate event involving one of the company’s key architects. The market is coming to this news with the...

Starbucks (NasdaqGS:SBUX) is contending with rising competitive pressure from rivals such as Luckin Coffee in China, Paris Baguette in the US, and McDonald's, which is seeing stronger traction with younger US consumers. The company is seeing lower engagement among users aged 17 to 25 on its app, raising questions about its appeal to younger customers. Dividend growth at Starbucks has slowed sharply, and the current payout is higher than net income, which is prompting fresh scrutiny of how...